core

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growthNovartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum…

4 months ago
Core Molding Technologies Reports Fiscal 2024 Third Quarter ResultsCore Molding Technologies Reports Fiscal 2024 Third Quarter Results

Core Molding Technologies Reports Fiscal 2024 Third Quarter Results

COLUMBUS, Ohio, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the…

5 months ago
Show previous Posts